본문 바로가기 주메뉴 바로가기

R&D

ONX-1006 Nanoparticle Cancer Treatment

ONX-1006 carries paclitaxel (PTX), a widely used chemotherapy drug, chemically bound in stable nanoparticles designed to concentrate PTX in tumors while protecting normal cells.

Manufactured through a proprietary 16-step process using biocompatible and biodegradable nanoparticles.

Supported by over 30 preclinical tests and 4,000 pages of data.

Demonstrated 20% greater tumor reduction than Abraxane at the same weekly PTX dose and the highest tumor cell death in the test.

Demonstrated no side effects at the specified doses in rat and beagle dog GLP toxicity studies.

Water-dispersible nanoparticles measuring about 30–60 nm, about one thousandth the width of a human hair.
※ A nanometer (nm) is one billionth of a meter (10⁻⁹ m).

PTX-loaded nanoparticle for tumor-homing drug delivery
PTX-Loaded Nanoparticle for Tumor-Homing Drug Delivery